1005009-98-2

Usage

Uses

Used in Pharmaceutical Synthesis:
N-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE is used as a building block in the synthesis of pharmaceutical compounds. Its unique structure and functional groups may enable the development of new drugs with improved therapeutic properties.
Used as a Reagent in Organic Chemistry Reactions:
In the field of organic chemistry, N-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE serves as a reagent that can facilitate various chemical reactions. Its presence may enhance reaction efficiency, selectivity, or yield, making it a valuable tool for chemists.
Used in the Development of New Materials:
N-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-AMINE may also be utilized in the development of new materials with specific properties. Its incorporation into materials could lead to advancements in areas such as polymer science, materials chemistry, or nanotechnology.

Upstream product

• 74-89-5 methylamine 
• 444120-94-9 2-chloro-5-(4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 84539-30-0 5-bromo-N-methylpyridin-2-amine 
• 73183-34-3 bis(pinacol)diborane 

Relevant academic research and scientific papers

HETEROARYL COMPOUNDS AND USES THEREOF

Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.

SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS

Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.

SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS

Provided are certain pyridopyrazine compounds, pharmaceutical compositions thereof and methods of use therefor.

PYRAZOLE COMPOUNDS

The present invention is directed to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.

2,4-SUBSTITUTED QUINAZOLINES AS LIPID KINASE INHIBITORS

The invention relates to compounds of the formula (I), which are appropriate for the treatment of kinase, e.g. PI3K-related, diseases, such as proliferative diseases, inflammatory diseases, obstructive airways disorders and transplantation related disease

NOVEL HETEROARYL SUBSTITUTED BENZOTHIAZOLES

The present invention relates to novel heteroaryl substituted benzothiazole derivatives, precursors thereof, and therapeutic uses for such compounds, having the structural formula (I) below: [Chemical formula should be inserted here. Please see paper copy